NuTech Inc is a US-based company operating in industry. The company is headquartered in Tyler, Texas. NuTech, Inc. is an independently owned, commercial nuclear and infusion pharmacy corporation operating pharmacies in Tyler, College Station and Wichita Falls, Texas. The company offers a range of products, which include Tc-99m Unit Dose Radiopharmaceuticals, Other Unit Dose Radiopharmaceuticals, Adjunctive Pharmaceuticals, and Interventional Agents. Its Tc-99m Unit Dose Radiopharmaceuticals offers Albumin Aggregated (MAA), Bicisate (Neurolite), Exametazime (Ceretec), Medronate (MDP), Mebrofenin (Choletec), Oxidronate (HDP), Pyrophosphate (PYP), and others. Its Other Unit Dose Radiopharmaceuticals offers Carbon-14 Urea (PYtest Kit), Capromab pendetide (Prostascint), F-18 Fluorodeoxyglucose, Gallium-67, and others. Its Adjunctive Pharmaceuticals and Interventional Agents offers Adenosine (Adenoscan), Regadenoson (Lexiscan), Aminophylline Injection, Sincalide (Kinevac Injection), Dipyridamole, Dobutamine Injection, and Ultratag RBC Kit.
根据最新的财务报表(Form-10K),Gladstone Capital Corp 的总资产为 $0,净亏损为 $0
NTCI 的关键财务比率是什么?
Gladstone Capital Corp 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
NuTech Inc 的收入按细分市场或地理位置如何划分?
Gladstone Capital Corp 最大收入来源是 Investment and Related Activities,在最近的收益报告中收入为 102,580,000。就地区而言, United States 是 Gladstone Capital Corp 的主要市场,收入为 102,580,000。